In this research, the significant amelioration of SX on NAFLD rats was concerned with the expression of apoB48 and PPARα, the regulation of gut microbiota, and intestinal barrier function. This evidence concerns the gene APOB and metabolic dysfunction-associated steatotic liver disease.